Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M406Revenue $M81.1Net Margin (%)-82.1Z-Score-1.1
Enterprise Value $M298EPS $-1.7Operating Margin %-57.5F-Score3
P/E(ttm))0Cash Flow Per Share $-0.5Pre-tax Margin (%)-82.5Higher ROA y-yY
Price/Book3.410-y EBITDA Growth Rate %0Quick Ratio6.6Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %22.2Current Ratio7.5Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-25.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-70.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M103ROI % (ttm)-46.5Gross Margin Increase y-yN

Gurus Latest Trades with VVUS

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VVUSJohn Burbank 2014-06-30 Sold Out -0.23%$4.59 - $6.18
($5.14)
$ 3.95-23%Sold Out0
VVUSJohn Burbank 2014-03-31 Reduce-1.37%$5.6 - $9.55
($7.2)
$ 3.95-45%Reduce -75.95%1,425,000
VVUSJohn Burbank 2013-12-31 Add0.15%$8.235 - $11.19
($9.67)
$ 3.95-59%Add 9.22%5,925,000
VVUSJohn Burbank 2013-09-30 Reduce-1.27%$9.45 - $14.99
($12.54)
$ 3.95-68%Reduce -36.22%5,425,000
VVUSJohn Burbank 2013-06-30 Reduce-0.46%$10.43 - $15.1
($12.91)
$ 3.95-69%Reduce -10.99%8,505,148
VVUSJean-Marie Eveillard 2013-06-30 Sold Out -0.01%$10.43 - $15.1
($12.91)
$ 3.95-69%Sold Out0
VVUSJohn Burbank 2013-03-31 Add0.27%$10.2 - $14.87
($12.43)
$ 3.95-68%Add 6.9%9,554,858
VVUSJean-Marie Eveillard 2013-03-31 Buy 0.01%$10.2 - $14.87
($12.43)
$ 3.95-68%New holding, 200000 sh.200,000
VVUSJohn Burbank 2012-12-31 Add0.8%$10.24 - $22.86
($14.58)
$ 3.95-73%Add 21.15%8,938,268
VVUSGeorge Soros 2012-09-30 Sold Out -0.06%$17.81 - $29.93
($23.45)
$ 3.95-83%Sold Out0
VVUSJohn Burbank 2012-06-30 Add0.73%$21.5 - $28.68
($24.02)
$ 3.95-84%Add 10.12%8,136,600
VVUSGeorge Soros 2012-06-30 Reduce-0.09%$21.5 - $28.68
($24.02)
$ 3.95-84%Reduce -64.93%150,000
VVUSJohn Burbank 2012-03-31 Add2.35%$9.99 - $23.78
($14.83)
$ 3.95-73%Add 72.22%7,388,793
VVUSGeorge Soros 2012-03-31 Buy 0.14%$9.99 - $23.78
($14.83)
$ 3.95-73%New holding, 427750 sh.427,750
VVUSGeorge Soros 2011-03-31 Sold Out $6.06 - $11.2
($7.95)
$ 3.95-50%Sold Out0
VVUSGeorge Soros 2010-12-31 Buy $5.94 - $9.78
($7.38)
$ 3.95-46%New holding, 19400 sh.19,400
VVUSDaniel Loeb 2010-06-30 Sold Out -0.62%$8.71 - $13.2
($10.68)
$ 3.95-63%Sold Out0
VVUSDaniel Loeb 2010-03-31 Buy 0.62%$8.24 - $10.54
($9.06)
$ 3.95-56%New holding, 1000000 sh.1,000,000
VVUSLee Ainslie 2008-12-31 Sold Out -0.01%$4.75 - $6.64
($5.7)
$ 3.95-31%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VVUS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VVUS John Burbank 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


VVUS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fischer Seth H.Z.CEO 2014-03-11Buy3,080$6.07-34.93view
DENNER ALEXANDER JDirector 2013-11-11Buy566,844$8.59-54.02view
MORRIS TIMOTHY EVP, Finance and CFO 2013-09-05Sell10,654$11.95-66.95view
ASTRUE MICHAEL JDirector 2013-09-04Buy10,000$11.96-66.97view
BIRO JON CSEE REMARKS 2013-06-27Buy2,000$12.85-69.26view
MARIO ERNESTDirector 2013-05-29Buy15,000$14.68-73.09view
MARIO ERNESTDirector 2012-08-20Buy5,000$20.75-80.96view
CASAMENTO CHARLES JDirector 2012-08-20Sell8,000$20.63-80.85view
SHORTLIFFE LINDA M DAIRIKIDirector 2012-08-14Sell18,000$22.72-82.61view
LOGAN MARK BDirector 2012-08-14Sell49,816$23.13-82.92view

Press Releases about VVUS :

    Quarterly/Annual Reports about VVUS:

    News about VVUS:

    Articles On GuruFocus.com
    Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
    Weekly Three-Year Low Highlight: VVUS, RALY, WILN, COVS Mar 25 2014 
    Billionaires Hold Four Stocks, 59% Off Sep 30 2013 
    Unique Investor Kyle Bass Unloads Five May 29 2013 
    Weekly Guru Bargains Highlights: FTE, VVUS, PAY, TIBX, VMW Feb 24 2013 
    Weekly Guru Bargains Highlights: FTNT, VVUS, HAE, PC, TIBX Dec 09 2012 
    Weekly Guru Bargains Highlights: CIG, PWE, VVUS, EBR, ATHN Dec 03 2012 
    Passport’s John Burbank Boosts VIVUS Stake to 8.5 Pct of Company Nov 02 2012 
    Weekly Top Insider Buys: IRM, JCP, APU, CAB, VVUS Aug 27 2012 
    Weekly CEO Sells Highlight: Splunk Inc, eBay Inc, Skyworks Solutions Inc, and VIVUS Inc. Jul 28 2012 


    More From Other Websites
    Most active Nasdaq-traded stocks Sep 30 2014
    [video] Zafgen CEO: 2015 Will Be Data Rich Year for Obesity Treatment Sep 30 2014
    VIVUS and Auxilium Announce Stendra Label Expansion Sep 19 2014
    VIVUS Inc. (VVUS) Rises: Stock Adds 12.4% in Session Sep 19 2014
    Rite Aid and Pier 1 are big market movers Sep 18 2014
    Rite Aid and Pier 1 are big market movers Sep 18 2014
    UPDATE 1-Vivus' Stendra gets FDA approval for use 15 minutes before sex Sep 18 2014
    US STOCKS-Banks rally on rate outlook, lead S&P 500 to new high Sep 18 2014
    FDA OKs faster-acting label for ED drug Stendra Sep 18 2014
    FDA OKs faster-acting label for ED drug Stendra Sep 18 2014
    VIVUS, Inc.’s Stendra lets you get it up faster Sep 18 2014
    [$$] Stendra Gets FDA Approval as 'On-Demand' Drug Sep 18 2014
    Why VIVUS (VVUS) Stock Is Up Today Sep 18 2014
    Vivus, Inc. Opens Sharply Higher On ED Drug Marketing Approval Sep 18 2014
    US STOCKS-Wall Street set to open higher, S&P 500 eyes record Sep 18 2014
    Pharmalot, Pharmalittle: We're Reading About Vivus, Gilead and Lots More!! Sep 18 2014
    VIVUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 18 2014
    VIVUS and Auxilium Announce FDA Approval of STENDRA sNDA; STENDRA Now First and Only Oral Erectile... Sep 18 2014
    VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile... Sep 18 2014
    VIVUS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Sep 16 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK